Drug class
5-alpha Reductase Inhibitor
Mechanism of action
5-alpha Reductase Inhibitors [MoA]
General use cases
- Prostatic Hyperplasia
- symptomatic BPH in men with an enlarged prostate
- prostate cancer
- symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
